SMS Pharma is a value added stock in small cap pharma sector. Recently gone into split mode, it has reasonably good EPS and better earning than other players. With ROE of around 20 and well set on CRR of 95% (in other words which implies that management concentrate on growth plans) and virtually a debt free company, it can test the price of Rs. 150 in the coming times in good market conditions.
Invest giving SIP like approach.